LTERT and female genital cancer: health benefits and groundless risks

Journals
Journal of Men's Health Frontiers in Bioscience-Elite Frontiers in Bioscience-Scholar Frontiers in Bioscience-Landmark Journal of Integrative Neuroscience Reviews in Cardiovascular Medicine Journal of Molecular and Clinical Medicine European Journal of Gynaecological Oncology Clinical and Experimental Obstetrics & Gynecology
Resources
For Authors For Reviewers For Editors Article Processing Charges Open Access Editorial Policies Publishing Ethic Copyright & License Digital Archive Privacy Policy Advertising Policies Peer Review Policy Special Issues & Supplements Policy
About
Overview Management Team Contact Us
Search

Submit

NULL

Section

All sections

Countries | Regions

Countries | Regions

Article Types

Article Types

Year

—

Volume

Issue

Pages

—

Search

IMR Press / EJGO / Volume 18 / Issue 1 / pii/1997101

Review for EJGO

Cite this article

Nanoparticles: Properties, applications and toxicities

1

Downloads

3

Views

Article Versions

Full-Text PDF
Related Info Link

Google Scholar
More by Author(s) Link

Journal Browser

Volume | Year

Issue

Search

Forthcoming Issue

Tweets By IMR Press_series

Announcements

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Editorial

LTERT and female genital cancer: health benefits and groundless risks

¹ Department of Human Pathology and Oncology, University of Siena, Italy

Eur. J. Gynaecol. Oncol. 1997, 18(1), 5–8;

Published: 10 February 1997

Previous article in this issue

Next article in this issue

Share

Back to top

Eur. J. Gynaecol. Oncol. Print ISSN 0392-2936 Electronic ISSN 2709-0086